Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Cancer Discovery|June 11, 2014
Defining key signaling nodes and therapeutic biomarkers in NF1-mutant cancersClare F Malone, Jody A Fromm, Ophélia Maertens, et al.Proceedings of the National Academy of Sciences of the United States of America|June 7, 2005
The NF1 tumor suppressor critically regulates TSC2 and mTORCory M Johannessen, Elizabeth E Reczek, Marianne F James, et al.Plos Biology|April 27, 2023
Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDACAmy E Schade, Ryan Kuzmickas, Carrie L Rodriguez, et al.Cancer Research|March 20, 2023
DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon CancerAbigail L Miller, Naiara Perurena, Alycia Gardner, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2005
ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell linesJeffrey A Engelman, Pasi A Jänne, Craig Mermel, et al.The Journal of Clinical Investigation|May 10, 2016
Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancersRebecca Lock, Rachel Ingraham, Ophélia Maertens, et al.Cancer Cell|December 13, 2006
A negative feedback signaling network underlies oncogene-induced senescenceStéphanie Courtois-Cox, Sybil M Genther Williams, Elizabeth E Reczek, et al.Cancer Cell|September 14, 2013
The RasGAP gene, RASAL2, is a tumor and metastasis suppressorSara Koenig McLaughlin, Sarah Naomi Olsen, Benjamin Dake, et al.Cancer Discovery|October 1, 2017
mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven TumorsClare F Malone, Chloe Emerson, Rachel Ingraham, et al.Iscience|July 27, 2020
Imaging Mass Spectrometry Reveals Tumor Metabolic HeterogeneityYang Zhang, Christelle Guillermier, Thomas De Raedt, et al.Pageof 6